Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

Ayşe Büyükcam1, Hüseyin Güdücüoğlu2, Kamuran Karaman3

  • 1a Hacettepe University Faculty of Medicine , Department of Pediatrics, Unit of Infectious Diseases , Ankara , Turkey.

Insights

Invasive pneumococcal infections in children remain a concern. Two pediatric cases of non-vaccine serotype 15A invasive pneumococcal infection were reported in Turkey post-vaccine implementation, highlighting the need for ongoing serotype surveillance.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Microbiology

Background:

  • Invasive pneumococcal infections (IPIs) pose a significant global public health challenge, particularly in pediatric populations.
  • Turkey integrated the pneumococcal conjugate vaccine (PCV) into its National Immunization Programme in 2009 to combat IPIS.
  • Continued surveillance is crucial to understand the evolving landscape of Streptococcus pneumoniae serotypes.

Observation:

  • This study documents the first two pediatric cases of IPIS caused by Streptococcus pneumoniae serotype 15A in Turkey.
  • These cases occurred following the widespread implementation of the pneumococcal conjugate vaccine in the country.
  • Serotype 15A is not covered by the currently utilized pneumococcal conjugate vaccine formulations.

Findings:

  • The emergence of invasive pneumococcal infection due to non-vaccine serotype 15A in vaccinated children indicates a potential shift in circulating serotypes.
  • This finding suggests that Streptococcus pneumoniae may be undergoing selective pressure, leading to the increased prevalence of non-vaccine serotypes.
  • The observed cases underscore the limitations of current PCVs in providing complete protection against all invasive pneumococcal serotypes.

Implications:

  • Local seroepidemiologic data are essential for monitoring the impact of vaccination programs and detecting shifts in pathogen populations.
  • Continuous surveillance for non-vaccine serotypes is critical for informing public health strategies and vaccine development.
  • Understanding serotype distribution is vital for adapting immunization programs to maintain high levels of protection against invasive pneumococcal disease.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.0K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
691
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K